HOLOSTEM TERAPIE AVANZATE
Holostem is the first biotechnology company entirely dedicated to the development, production, registration and distribution of advanced therapy medicinal products (ATMPs) based on epithelial stem cell cultures for cell and gene therapy.
HOLOSTEM TERAPIE AVANZATE
Industry:
Biotechnology
Founded:
2008-01-01
Address:
Modena, Emilia-Romagna, Italy
Country:
Italy
Website Url:
http://www.holostem.com
Total Employee:
11+
Status:
Active
Contact:
+39 059 2058070
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.holostem.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: lhwp2018.webapps.net
- IP address: 185.2.5.18
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Holostem Terapie Avanzate"
Holostem Terapie Avanzate begins its transition to a Foundation
Jun 3, 2022 The board of directors unanimously approved the company’s evolution into a nonprofit organization Holostem will remain an international point of reference for patients and …See details»
Holostem Srl - medicina rigenerativa da cellule staminali epiteliali
HOLOSTEM S.r.l. a Socio Unico c/o Centro di Medicina Rigenerativa “Stefano Ferrari” Via Glauco Gottardi 100 – 41125 Modena Tel. +39 059 205 80 70 | Fax +39 059 205 81 15 | …See details»
Holostem S.r.l.
Jun 26, 2018 HOLOSTEM S.r.l. a Socio Unico c/o Centro di Medicina Rigenerativa “Stefano Ferrari” Via Glauco Gottardi 100 – 41125 Modena Tel. +39 059 205 80 70 | Fax +39 059 205 81 15 | [email protected] C.F., P. IVA e …See details»
Holostem S.r.l. - LinkedIn
Holostem S.r.l. | 4,295 followers on LinkedIn. Holostem S.r.l. is the first biotechnological company entirely devoted to research, development, manufacture, registration and distribution of ...See details»
Stem-cell therapy company saved by public funds - Nature
Holostem Terapie Avanzate - Crunchbase Company …
Holostem is developing ex vivo gene therapy for various forms of Epidermolysis Bullosa, involving the transplantation of genetically corrected epidermal stem cells. Cell Therapy: Holostem provides cell therapy using autologous limbal …See details»
Italy’s stem-cell pioneer at risk - Nature
Dec 8, 2022 The Modena-based company Holostem, which introduced the first stem-cell based therapy approved in Europe, may have to close after its main investor has withdrawn. The Modena-based company Holostem ...See details»
Holostem: il salvataggio da parte del Mimit fondamentale per i …
Dec 1, 2023 Holostem Terapie Avanzate in liquidazione esprime soddisfazione per il decisivo passo che porterà all’acquisizione dell’azienda da parte di Fondazione Enea Tech e …See details»
Our company - Holostem S.r.l.
Holostem is the first biotechnological company entirely devoted to development, manufacture, registration and distribution of Advanced Therapies Medicinal Products (ATMPs) based on …See details»
Holostem Terapie Avanzate: Leading the Revolution in the …
Holostem is the first biotechnological company entirely devoted to the development, manufacture, registration, and distribution of Advanced Therapies Medicinal Products (ATMPs) based on …See details»
Holostem Company Profile - Office Locations, Competitors ... - Craft
Holostem Terapie Avanzate is a biotech company devoted to the development, manufacture, registration, and distribution of Advanced Therapies Medicinal Products (ATMPs) based on …See details»
Holostem Terapie Avanzate Interview - Italy Life Sciences 2021
Holostem’s business model relies on one technology platform for regenerative medicine for various applications, so the capacity expansion could also be spared for other indications like …See details»
Holostem Terapie Avanzate Srl - Drug pipelines, Patents, Clinical ...
Explore Holostem Terapie Avanzate Srl with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 2 news, and 14 literature, Technology Platform:Stem cell therapy, …See details»
About us - Holostem S.r.l.
HOLOSTEM S.r.l. a Socio Unico c/o Centro di Medicina Rigenerativa “Stefano Ferrari” Via Glauco Gottardi 100 – 41125 Modena Tel. +39 059 205 80 70 | Fax +39 059 205 81 15 | …See details»
Chiesi and Holostem Announce FDA Orphan Drug Designation
Jun 12, 2018 Its R&D organization is headquartered in Parma (Italy), and integrated with 6 other key R&D groups in France, the USA, the UK, Sweden, and Denmark to advance Chiesi's pre …See details»
Chiesi Group and Holostem Terapie Avanzate announce transfer of ...
Parma and Modena, 16 June 2020 – Chiesi Farmaceutici, international research-focussed group (Chiesi Group), and Holostem Terapie Avanzate, top Italian biotech company entirely …See details»
Management - Holostem S.r.l.
HOLOSTEM S.r.l. a Socio Unico c/o Centro di Medicina Rigenerativa “Stefano Ferrari” Via Glauco Gottardi 100 – 41125 Modena Tel. +39 059 205 80 70 | Fax +39 059 205 81 15 | …See details»
Chiesi and Holostem Announce FDA Orphan Drug Designation for …
Its R&D organization is headquartered in Parma (Italy), and integrated with 6 other key R&D groups in France, the USA, the UK, Sweden, and Denmark to advance Chiesi's pre-clinical, …See details»
Cost and availability of novel cell and gene therapies:
Jan 2, 2023 On 24 November 2022, Valline Holding Srl decided to withdraw their financial support to Holostem, the company that developed Holoclar®, the first stem cell‐based ATMP …See details»
News - Holostem S.r.l.
HOLOSTEM S.r.l. a Socio Unico c/o Centro di Medicina Rigenerativa “Stefano Ferrari” Via Glauco Gottardi 100 – 41125 Modena Tel. +39 059 205 80 70 | Fax +39 059 205 81 15 | …See details»